{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["17(24)"],"submitter":["Timiryasova A"],"pubmed_abstract":["<b>Background/Objectives</b>: Whilst cancer is a leading cause of death in people with HIV, less is known about clinical outcomes after cancer. <b>Methods</b>: Participants from the RESPOND and D:A:D cohorts with the five most common cancers (Kaposi's sarcoma (KS); non-Hodgkin lymphoma (NHL); and lung, anal and prostate cancers) were followed from first cancer diagnosis after 2006/2012 [D:A:D/RESPOND] until death, final follow-up or administrative censoring (2016/2021). Incidence rates (IR) were calculated for post-cancer mortality; for non-fatal events (cardiovascular disease, diabetes, another primary cancer, AIDS events) individually and as a non-fatal composite clinical outcome (CCO). Predictors or mortality and CCO were assessed using Poisson regression with generalized estimating equ"],"journal":["Cancers"],"pagination":["4000"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12731807"],"repository":["biostudies-literature"],"pubmed_title":["Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration."],"pmcid":["PMC12731807"],"pubmed_authors":["Egle A","Cingolani A","Grabmeier-Pfistershammer K","Marongiu A","On Behalf Of The D A D And Respond Study Groups","Amstutz A","Wit F","Bonnet F","Bottanelli M","Garges H","Peters L","Lehmann C","Castagna A","Domingo P","Young LA","Timiryasova A","Petoumenos K","Lundgren J","Greenberg L","Tarr PE","Carlander C","Martin C","Sabin CA","Hosein S","Mussini C","Ryom L"],"additional_accession":[]},"is_claimable":false,"name":"Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration.","description":"<b>Background/Objectives</b>: Whilst cancer is a leading cause of death in people with HIV, less is known about clinical outcomes after cancer. <b>Methods</b>: Participants from the RESPOND and D:A:D cohorts with the five most common cancers (Kaposi's sarcoma (KS); non-Hodgkin lymphoma (NHL); and lung, anal and prostate cancers) were followed from first cancer diagnosis after 2006/2012 [D:A:D/RESPOND] until death, final follow-up or administrative censoring (2016/2021). Incidence rates (IR) were calculated for post-cancer mortality; for non-fatal events (cardiovascular disease, diabetes, another primary cancer, AIDS events) individually and as a non-fatal composite clinical outcome (CCO). Predictors or mortality and CCO were assessed using Poisson regression with generalized estimating equ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Dec","modification":"2026-05-28T03:17:50.268Z","creation":"2026-05-28T03:07:26.209Z"},"accession":"S-EPMC12731807","cross_references":{"pubmed":["41463249"],"doi":["10.3390/cancers17244000"]}}